3 results
Euglycemic Diabetic Ketoacidosis (EuDKA)
SGLT2 Inhibitors
Increasing Indications
Significant Adverse Drug Effects
Definition of EuDKA
 • Metabolic acidosis with pH
Ketoacidosis (EuDKA ... level < 200 mg/dL Pathophysiology ... of EuDKA by Gillian ... #diagnosis #management ... #endocrinology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Pathophysiology ... Diagnosis: • ... Barre #Syndrome #diagnosis ... #management #treatment ... #neurology
Transverse Myelitis Overview

Focal inflammatory disorder of the spinal cord resulting in rapid onset of weakness, sensory
monophasic Pathophysiology ... Presentation: Injury ... extensors of the arms ... bouts of HTN Diagnostic ... #management #neurology